Through Nextmune, Vimian acquires Laboratoire de Dermo-Cosmétique Animale (LDCA), a French pet dermatology specialist company that provides innovative and evidence-based natural topical products for the wellbeing of animals through its Dermoscent® brand.
LDCA, is a companion animal dermatology specialist company that provides prescribing veterinarians and pet owners with innovative and natural topical products to complement medicinal treatments and limit excessive use of medicines through a multimodal approach. Every product formula is proprietary and developed by a team of veterinary dermatologists and pharmaceutical specialists. The brand Dermoscent® is acknowledged by both veterinarians and pet owners. Founded in 2003 with products distributed in more than 45 countries, LDCA has revenues of approximately EUR 5 million over the last twelve months.
On the 22 of February, the winners of the “CEO of the Year” award were announced at Kistamässan in Stockholm. The winner in the Large-Cap category was David von Laskowski, Picadeli & Greenfood Group. “CEO of the Year” has beenRead more
Vegner Group Limited is a leading residential property management group in the UK with 475 employees, over 100,000 homes under management and a nationwide reach across 20 office locations. Vegner specializes in serving Residents Management Company (RMC) clients, bringing furtherRead more
Fidelio Capital acquires 10 million shares, around 2.2 percent of the capital, in the animal health company Vimian Group AB, effective 21 September 2023. Through the transaction, Fidelio will increase its ownership in Vimian, from 53 percent of the capitalRead more